isocarboxazid has been researched along with Idiopathic Parkinson Disease in 3 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jones, AB | 1 |
Pare, CM | 1 |
Nicholson, WJ | 1 |
Price, K | 1 |
Stacey, RS | 1 |
Figuerido, JA | 1 |
De la HerrĂ¡n, J | 1 |
Dandiya, PC | 1 |
Bhargava, LP | 1 |
1 trial available for isocarboxazid and Idiopathic Parkinson Disease
Article | Year |
---|---|
Brain amine concentrations after monoamine oxidase inhibitor administration.
Topics: Aged; Alkynes; Autopsy; Brain; Brain Stem; Caudate Nucleus; Chlorpromazine; Dopamine; Humans; Hypoth | 1972 |
2 other studies available for isocarboxazid and Idiopathic Parkinson Disease
Article | Year |
---|---|
[Personal experience in the treatment of Parkinson's disease with L-Dopa].
Topics: Adult; Aged; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Isocarboxazid; Male; Middle Age | 1970 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine | 1968 |